The tariff classification of LifeGlider from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated November 14, 2025, you requested a tariff classification ruling. The LifeGlider is a patented mobility assistance device designed for individuals who have difficulty walking or standing due to neurological, muscular, or balance impairments. Unlike standard rollators or walkers that require upper-body support, the LifeGlider transfers the user’s body weight through the hips and pelvis to the frame, enabling upright and hands-free mobility.
The device consists of two parallel side tubular steel frames joined by a hinge arm structure, a braking system, height-adjustable components to accommodate different users, a walking seat that bears part of the user’s weight, four wheels (front swivel, rear locking), and a seatbelt-style securing system that fastens around the waist to keep the user safely positioned while walking or standing.
This configuration allows the user to move freely while preventing falls and eliminating the need to hold the frame for balance. The LifeGlider is shipped fully assembled. The device provides controlled mobility and fall prevention for individuals with compromised balance, strength, or endurance. It is used in home, rehabilitation, and clinical environments by individuals with conditions such as multiple sclerosis, Parkinson’s disease, ataxia, cerebral palsy, or those in post-stroke recovery.
You state that the LifeGlider is exclusively designed for individuals with physical impairments that affect their ability to walk or maintain balance. These impairments are typically long-term and may result from medical conditions such as cerebral palsy, multiple sclerosis, Parkinson’s disease, muscular dystrophy, stroke, traumatic brain injury, or spinal cord injury.
The LifeGlider provides upright, hands-free mobility and fall prevention by supporting the user’s pelvis and hips rather than requiring arm strength for balance. It is not suitable or marketed for general public use. Based on internal sales data and customer feedback, the majority of LifeGlider users — approximately 95% — have permanent or chronic mobility impairments. A small percentage (less than 5%) use the LifeGlider temporarily during rehabilitation following injury or surgery.
In all cases, users experience substantial mobility limitations. The LifeGlider is unsuitable for non-disabled users due to its pelvic support system and structural design, which restrict normal gait but stabilize users with impaired balance. The product’s weight and controlled movement features make it cumbersome and unnecessary for able-bodied individuals. It is distributed exclusively through medical suppliers, rehabilitation professionals, and our own website.
It is not marketed in general consumer retail channels. The LifeGlider is used by individuals with substantial limitations in walking or standing, regardless of whether those impairments are permanent or temporary. Examples include individuals recovering from stroke or surgery, and those with degenerative neurological conditions such as multiple sclerosis or Parkinson’s disease.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N356032).